Organophosphate – CHEMPACK Program

Applies to adult and SOME pediatric patients

Criteria

  • This protocol is for delivering medications associated with the CHEMPACK Program
  • The CHEMPACK may be requested by any level practitioner for one or more patients with signs or symptoms of organophosphate/nerve agent toxicity
  • Signs and symptoms of organophosphate/nerve agent toxicity include any of:
  • SLUDGEM: Salivation-Lacrimation-Urination-Diarrhea-GI Distress-Emesis-Muscle Twitching-Miosis
  • Consult medical control before administering medications in this protocol to children younger than 8 years of age

EMT and up

  • Don appropriate PPE and decontaminate as needed
  • Contact dispatch to declare an incident and request appropriate response, including ALS
  • Request CHEMPACK Program Antidote Kits
  • Consider requesting an EMS physician to scene
  • ABCs and vital signs
  • Airway management and appropriate oxygen therapy
  • Ongoing assessment of the effectiveness of breathing, see as necessary:
  • Extremis: Respiratory Arrest / Failure – Adult
  • Extremis: Respiratory Arrest / Failure – Pediatric
  • Administer antidotes as follows to adults and children 8 years and older¹ based on signs and symptoms and using a route within your scope of practice and training. Atropine MUST be administered first:
  • Signs and Symptoms | | | Atropine Dose2, 3 | Pralidoxime (2- PAM) Dose2, 3, 4 | | Diazepam or | | Monitoring Frequency / | | | | | | Midazolam | | / | | | | | | Dose2, 5 | | / | SEVERE + SEIZURES | | 6 mg IM/IV | 1,800 mg IM/IV | 10 mg IM 5 mg IV | 10 mg IM | | Every 5 min / | SLUDGEM + Respiratory Distress | | | | | 5 mg IV | | / | Agitation/Confusion | | | | | | | / | SEVERE | | 6 mg IM/IV | 1,800 mg IM/IV | None | | | Every 5 min / | SLUDGEM + Respiratory Distress | | | | | | | / | Agitation/Confusion | | | | | | | / | MODERATE | | 4 mg IM/IV | 600 mg IM/IV | None | | | Every 10 min / | SLUDGEM | | | | | | | / | ASYMPTOMATIC | | None | None | None | | | Every 15 min / | No symptoms | | | | | | |

Key points

  • 1 Pediatric patients should be decontaminated and have expedited transport off scene, especially if they are demonstrating ANY signs or symptoms. Contact medical control before administering CHEMPACK medications to children younger than 8 years of age.
  • 2 CHEMPACK medications may come in prefilled autoinjectors, however the dose of each autoinjector may vary. Practitioners must sum the dose in each autoinjector and should administer enough autoinjectors and/or vials to achieve the total dose identified in the treatment table.
  • 3 All levels may administer Atropine and Pralidoxime using autoinjector. Combination autoinjectors (such as DuoDote®) that contain both Atropine and Pralidoxime (2-PAM) together may be used in place of the autoinjectors that contain the individual drugs.
  • CHEMPACK medications may be used regardless of the expiration date
  • CHEMPACK medications are NOT to be used for prophylaxis